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ORIGINAL AND CLINICAL ARTICLES
The first scales evaluating the patient conditions 
were designed in the 80-ties of the previous century 
and quickly became popular at intensive care units 
(ICUs) [1, 2]. Since that time, numerous new scales 
have been created or the existing ones modified in 
order to provide most accurate assessment of pa-
tients. They are the tools for validation of the thera-
peutic procedures used as well as for monitoring 
the quality and costs of treatment. The standardised 
assessment measures are also extremely useful dur-
ing prospective and retrospective studies, which, in 
turn, contribute to implementation of increasingly 
effective treatment options, both interventional and 
pharmacological [3]. 
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The best known scales include the Acute Physiol-
ogy and Chronic Health Evaluation II (APACHE II) and 
Simplified Acute Physiology Score II (SAPS II), which 
assess various physiological parameters and con-
sider the data regarding age, chronic diseases and 
history of surgeries. The scores of the above scales 
should be verified within the first 24 h following ICU 
admission, which enables us to assess the patient’s 
condition as well as to estimate the risk of death dur-
ing a particular hospitalisation [1]. Some parameters 
are common for both scales yet in some cases they 
were replaced with other factors determining the 
performance of the same systems. The largest differ-
ences concern concomitant chronic diseases [1, 2]. 
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Abstract
Background: Disease’s severity classification systems are applied to measure the risk 
of death and to choose the best therapy for patients admitted to intensive care unit 
(ICU). The aim of the study was to verify risk of death calculated with APACHE II (Acute 
Physiology and Chronic Health Evaluation II), SAPS II (Simplified Acute Physiology Score II), 
SOFA (Sequential Organ Failure Assessment) and evaluate correlation between these 
scores. The usefulness of SOFA score as a sole scale also was assessed. 
Methods: This was a retrospective study conducted in 30-beds ICU in Kraków, Poland. 
Every male and female patient over 18 years old who was admitted to the ICU between 
18.04.2016 and 12.08.2016 was included in the analysis. Patients who were transferred 
from another ICU were excluded from the research. APACHE II, SAPS II, SOFA were cal-
culated after admission using laboratory results and clinical examination. Discrimination 
and calibration were used to validate these scoring system. 
Results: Analysis included 86 patients. The outcomes were compared within survivors 
and non-survivors groups. The prediction of death was statistically significant only for 
APACHE II and SAPS II. The best AUROC was for APACHE II 0.737 and SAPS II 0.737; dis-
crimination for SOFA was not statistically significant. There was high correlation only 
between SAPS II and APACHE II results (r ≥ 0.7, P < 0.01). The calibration was excellent 
for SAPS II, P = 0.991, and slightly worse for APACHE II, P = 0.685, and SOFA, P = 0.540. 
Patients who survived spent more days on ICU (P < 0.01), mean Length of Stay (LOS) in 
this group was 38.25 ± 16.80 days.
Conclusions: APACHE II and SAPS II scales have better discrimination, calibration and 
power to predict deaths on ICU than SOFA. Among these scales SOFA did not achieve 
expected results.
Key words: APACHE II, SAPS II, SOFA, risk of death on admission, intensive care unit.
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The next scale that gains in popularity at ICUs 
is the Sequential Organ Failure Assessment (SOFA), 
originally termed Sepsis-related Organ Failure As-
sessment, which constitutes the basis for the cur-
rent definition of sepsis. SOFA is used for everyday 
assessment of the patient’s condition and is based 
on the parameters routinely monitored in the ICU 
settings; it includes parameters regarding the main 
body systems yet does not consider chronic dis-
eases, age or modes of admissions. This scale is an 
alternative to the extensive classifications, such as 
APACHE II or SAPS II, which include not only the ba-
sic vital parameters and point-of care testing (POCT) 
but also laboratory tests performed every several 
days or only once [4].
Depending on the ICU profile and reference 
degree, the effectiveness of APACHE II, SAPS II and 
SOFA in estimating the prognosis markedly differs. 
The present study was undertaken to evaluate 
the reliability of APACHE II and SAPS II in assess-
ing the risk of ICU death. Another objective was to 
determine whether the introduction of SOFA or re-
placement of the scales hitherto used with it could 
improve the effectiveness of death risk evaluation 
and treatment efficacy. 
METHODS
The study design was approved by the Bioeth-
ics Committee of the Jagiellonian University in Kra-
kow. The study encompassed patients treated in the 
30-bed ICU of the University Hospital in Krakow. 
The retrospective analysis included patients > 18 years 
of age admitted to the ICU between April 18, 2016 
and August 12, 2016. The patients transferred from 
another ICU were excluded. 
The study patients were assessed on admis-
sion with APACHE II and SAPS II using the calcu-
lators configured in the Infomedica system. The 
SOFA scores were calculated for the worst results 
within 24 hours after admission (https://www.the-
calculator.co/health/Sequential-Organ-Failure-As-
sessment-(SOFA)-Score-Calculator-862.html). The 
data entered to the formula were taken from the 
POCT analyser (concentration of bilirubin, creati-
nine, HCO3, blood pH, and PaO2), laboratory blood 
tests (PLT and WBC count, haematocrit), and neuro-
logical assessment according to the Glasgow Coma 
Scale (GCS). GCS was used on admission. The study 
population was divided into two groups: group 1 
– patients who died in the ICU (non-survivors) and 
group 2 – whose final point (outcome) was discharge 
from ICU or transfer to the conservative department 
(survivors). 
The APACHE II, SAPS II and SOFA results were 
statistically analysed as for discrimination, predic-
tion of death and calibration of tests. Discrimination 
was defined as the ability of a scale to differentiate 
between non-survivors and survivors. The satisfy-
ing discrimination result is assumed to be the area 
under a receiver operator characteristic (AUROC) 
> 0.70 [5]. Calibration was defined as the degree of 
agreement between the expected and the observed 
final point. 
Statistical analyses were performed using source 
data that consisted of qualitative and quantitative 
variables. Quantitative variables of normal distribu-
tion were compared using the Mann-Whitney U test. 
Inter-scale correlations were checked with the Pear-
son correlation. Discrimination was checked using 
ROC and AUROC curves. The Hosmer-Lemenshow 
test was applied for calibration. P < 0.01 was con-
sidered statistically significant. The STATISTICA 12 
(Statsoft, Tulsa, USA) software was applied for the 
analysis of data.
RESULTS
The study included 86 individuals; the mean age 
was 58.66 ± 20.71 years while the mean ICU length 
of stay (LOS) – 32.06 ± 18.86 days. 
Group 1 consisted of 25 patients (29%). Their ICU 
treatment was shorter compared to group 2 (U = 253, 
P < 0.01). Demographic characteristics of patients are 
presented in Table 1.
The means and medians of scores in various 
scales were calculated for both groups (Table 2). In 
group 2, the APACHE II and SAPS II scores were lower 
than in group 1 – 3.90 and 3.96, respectively; P < 0.01. 
There was no statistically significant intergroup dif-
TABLE 1. Demographic data of study patients
Parameter  Total Group of non-survivors Group of survivors P
Number of individuals (%) 86 (100) 25 (29.1) 61 (70.9) 
Gender
Female (%) 29 (33.7) 10 (40.0) 19 (31.1) 0.43
Male (%) 57 (66.3) 15 (60.0) 42 (68.9) 
Mean age (SD, years) 58.6 (20.71) 65.4 (20.46) 55.9 (20.34) 0.053
Mean ICU stay (SD, days) 32.06 (18.86) 16.96 (14.8) 38.25 (16.8) < 0.01
ICU – intensive care unit
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ference in SOFA scores on admission – group 1: 
15.2 (± 3.83), group 2: 14.0 (± 3.66), P = 0.18.
Based on the Pearson correlation coefficient, 
a strong correlation between SAPS II and APACHE II 
scores was found (r = 0.7, P < 0.01); otherwise, there 
was no correlation observed between SOFA versus 
SAPS II (P = 0.056) and APACHE II (P = 0.365) scores.
The ability to discriminate both study groups as 
to the risk of death using APACHE II, SAPS II and SOFA 
scales was presented in Figure 1. AUROC was found 
to be 0.738 – APACHE II, 0.737 – SAPS II and 0.579 – 
SOFA; only the first two scales showed statistical sig-
nificance in predicting death (very similar results).
The best calibration determined using the Hos-
mer-Lemenshow test was found for SAPS II (1.601; 
P = 0.991). The APACHE II and SOFA results were 
worse (4.798; P = 0.685; 5.033; P = 0.540, respectively).
DISCUSSION
In the present study, the APACHE II and SAPS II 
scales were found to be effective in reliable evalu-
ation of the risk of death on ICU admission. Their 
scores were higher in non-survivors, as compared to 
survivors (discharged or transferred from the ICU). 
No such a difference was observed in the case of 
SOFA. Additionally, APACHE II and SAPS II discrimi-
nation results were better compared to SOFA. 
Numerous papers have been published, com-
pring the effectiveness of the analysed scales in pre-
dicting mortality; however, the results of SOFA are 
ambiguous. The uselessness of this scale for predict-
ing mortality on ICU admission has been reported 
in one prospective study carried out in Canada [6]. 
In the above study, the data were collected accord-
ing to the recommendations described by the au-
thors of SOFA [4]. The results of 1436 patients have 
demonstrated poor calibration and discrimination 
(AUROC 0.67) [6]. On the other hand, some reports 
have confirmed the usefulness of SOFA for predict-
ing the risk of death on ICU admission (AUROC 
> 0.8) [7–9]. The retrospective study from New Delhi, 
performed to compare the new generation APACHE, 
SAPS, and SOFA scales with those used earlier, has 
demonstrated high discrimination (AUROC ~ 0.89) 
and poor calibration of SOFA and SAPS II scales [9]. 
In the above mentioned and some other stud-
ies comparing the usefulness of scales, the values 
for SOFA ranged from 0.67 to 0.84 [6–8, 10–13]. 
The worst AUROC result for APACHE II or SAPS II 
scales was 0.74 [14]. According to the studies com-
paring only SOFA with APACHE II or SAPS II, the 
AUROC result for SOFA was 0.70 while the APACHE II 
and /or SAPS II discrimination results II were more 
reliable [10, 11, 13, 15]. 
Some differences described above are likely to 
result from different approaches to the Glasgow 
Coma Scale (GCS) scores in ICU patients [2, 4, 16]. In 
cases of SAPS II and APACHE II scales, GCS should be 
evaluated before administering sedatives and im-
plementing mechanical lung ventilation [2, 16]. For 
the purposes of SOFA, the current score should be 
taken into account [4]. In our study, the evaluation 
of GCS was hindered – on admission to ICU, patients 
TABLE 2. APACHE II, SAPS II and SOFA scores of study patients presented as means ± SD (medians)
Parameter Total  Group of non-survivors  Group of survivors  P
APACHE II 24.15 ± 7.18 (25.0) 28.52 ± 6.48 (28.0) 22.36 ± 6.71 (23.0) < 0.01
SAPS II 58.61 ± 14.52 (58.0) 67.52 ± 13.85 (66.0) 54.9 ± 13.21 (54.5) < 0.01
SOFA 14.36 ± 3.73 (14.0) 15.2 ± 3.83 (14.0) 14.0 ± 3.66 (14.0) 0.18
APACHE II – Acute Physiology and Chronic Health Evaluation II, SAPS II – Simplified Acute Physiology Score II, SOFA – Sequential Organ Failure Assessment
FIGURE 1. The ROC curves for APACHE II, SAPS II and SOFA
APACHE II - Acute Physiology And Chronic Health Evaluation II, SAPS II -Simplified Acute Physiology Score II, 
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TABLE 3. Comparison of discrimination and calibration of APACHE II, 
SAPS II and SOFA
Parameter  AUROC Hosmer-Lemenshow test, P
APACHE II 0.738 0.685 
SAPS II 0.737 0.991
SOFA 0.579 0.540
AUROC – the Area under a Receiver Operating Characteristic, APACHE II - Acute Physiology And 
Chronic Health Evaluation II, SAPS II -Simplified Acute Physiology Score II, SOFA – Sequential 
Organ Failure Assessment 
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were usually sedated at the Emergency Department 
or during anaesthesia. Moreover, the evaluation of 
GCS in intubated patients remains debatable, which 
is essential for SOFA, as this parameter plays an im-
portant role in it. 
As far as calibration is concerned, our findings 
demonstrated the best results for SAPS II (P = 0.991), 
slightly worse for APACHE II (P = 0.685) and the 
worst ones for SOFA (P = 0.540). The above findings 
are consistent with the results reported by other 
centres showing better calibrations for the first two 
scales, i.e. 0.079–0.811 [9, 10, 13, 14] and 0.189–0.86 
[9, 11, 13, 14], respectively, as compared to SOFA: 
0.301–0.437 [9, 11, 13, 15].
The reports validating the scales in Polish ICUs 
are scarce. The only data reported in literature come 
from the Gdansk and Łodz centres where SAPS II, 
APACHE II and SOFA scales were validated for pre-
dicting mortality. Sawicka et al. [17] evaluated pa-
tients with diseases of the haemopoietic system. 
The Łodz centre validated the scales for patients 
with meningococcal cerebrospinal meningitis. Ac-
cording to both studies, all three scales have been 
found useful. However, only the SAPS II scale was as 
an independent factor of the risk of death [17, 18]. 
In our study, the mean results of all three scales on 
ICU admission were comparable. 
The comparison of the mean ICU length of stay 
with the data of other studies [11, 14, 19] clearly 
showed a significantly longer stay in the Krakow 
ICU, which was particularly evident in group 2 – 
38.25 days (± 16.8); in group 1, the mean length 
of stay was 16.96 days (± 14.8), which is also long. 
In the studies cited, the mean ICU treatment time 
in patients discharged or transferred from the ICU 
ranged from 4.0 to 8.42 days and in the group of 
non-survivors – 5.3–7.51 days [11, 14, 19]. 
The issue of the length of ICU stay under the 
conditions of the Polish health care system has been 
disputed multiple times. In 2014, Adamski et al. [20] 
presented the data comparing the functioning of 
ICUs in Poland (Olsztyn) and Finland (Pori) and dem-
onstrated radical differences in the mean length of 
ICU stay (14 and 4.2 days, respectively). According to 
the authors, the causes of such differences include 
the lack of legal regulations about the principles 
regarding maintenance/withdrawal of treatment 
and procedures (“do not resuscitate”), the lack of 
planned care of chronically ill patients after dis-
charge from ICUs and lack of intermediate facilities 
in the Polish health care system dealing with further 
treatment of patients discharged from ICUs and be-
fore admission to the conservative departments. 
Moreover, in Poland, almost 50% of patients were 
admitted to ICUs from other hospital departments 
while in Finland, admissions from the emergency 
departments predominate [20]. Such results point 
to the problem of too late response to the gradu-
ally deteriorating conditions of patients treated in 
hospital departments. 
In our study, many factors, often dependent 
on the Polish health care conditions, affected high 
scores in the scales used, very long ICU hospitalisa-
tions, as well as treatment outcomes. They include 
a wide profile of patients admitted to ICUs, lack 
of management standards, lack of an appropriate 
system of transferring patients who do not require 
further treatment from ICU to other departments or 
facilities, and limited availability of diagnostic and 
therapeutic methods. Our analysis demonstrated 
that despite the lack of efficiency of SOFA in pre-
dicting death on ICU admission, its usefulness for 
continuous assessment of ICU patients was not ne-
gated. Everyday assessment of patients according 
to SOFA and analysis of changes in the results ob-
served in the successive days could be an additional 
element of making therapeutic decisions [21].
The present study was performed as initial re-
search for further analysis, verifying the usefulness 
of using scales on admission to the ICU in Krakow. 
The objective was to improve individual assessment 
of patients on ICU admission by using one most ef-
fective scale and take therapeutic decisions based 
on objective clinical data. Further research should 
include larger study populations of patients, divided 
according to the cause of hospitalisation and use 
newer assessment scales, e.g. SAPS III, which has 
showed high discrimination and calibration in nu-
merous studies. 
CONCLUSIONS
In our centre, APACHE II and SAPS II scales hith-
erto used are the reliable tools estimating the risk of 
death on ICU admission (to the Department of In-
tensive Therapy in Krakow). Given good discrimina-
tions and high calibrations of both tests, one should 
consider whether the use of both similar scales is 
required. 
The introduction of SOFA on ICU admission 
would not improve the efficacy of predicting death. 
Considering the specificity of functioning of the 
Polish health care system and long hospitalisations, 
it seems necessary to perform additional assess-
ments of patients according to scales during ICU 
treatment and analyse the results according to the 
outcomes. 
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